Shkreli, then the head of Turing Pharmaceuticals (later called Vyera), became known as “Pharma Bro” after raising the price on Daraprim, a medication used by many AIDS and cancer patients, to $750 from $13.50.
He was found guilty in 2017 on two counts of securities fraud and one count of conspiracy to commit securities fraud, receiving a seven-year sentence in 2018. Those charges weren’t related to the Daraprim price hike, but he’s still banned for life from the pharmaceuticals industry.
Exactly why Shkreli, 39, was released early may be up for debate, although famed essayist and mathematician Nassim Nicholas Taleb floated one theory.
Martin Shkreli, has been released EARLY from federal prison. It was not for good behavior; he was so unbearable they wanted to have some mercy on the personnel. https://t.co/rRMrEEVCtR via @WSJ